165 related articles for article (PubMed ID: 6144127)
1. Serum neuroleptic concentrations and clinical response: a radioreceptor assay investigation of acutely psychotic patients.
Kucharski LT; Alexander P; Tune L; Coyle J
Psychopharmacology (Berl); 1984; 82(3):194-8. PubMed ID: 6144127
[TBL] [Abstract][Full Text] [Related]
2. Neuroleptic serum levels measured by radioreceptor assay and clinical response in schizophrenic patients.
Tune LE; Creese I; DePaulo JR; Slavney PR; Snyder SH
J Nerv Ment Dis; 1981 Jan; 169(1):60-3. PubMed ID: 6108981
[TBL] [Abstract][Full Text] [Related]
3. Neuroleptic monitoring: relation between antipsychotic efficiency and radioreceptor assay of serum haloperidol.
Odou P; Vaiva G; Luyckx M; Brunet C; Dine T; Gressier B; Cazin M; Cazin JC
Eur J Clin Pharmacol; 1996; 50(5):357-63. PubMed ID: 8839656
[TBL] [Abstract][Full Text] [Related]
4. Serum haloperidol concentrations and clinical response in acute psychosis.
Miller DD; Hershey LA; Duffy JP; Abernethy DR; Greenblatt DJ
J Clin Psychopharmacol; 1984 Dec; 4(6):305-10. PubMed ID: 6511996
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of neuroleptics measured by dopamine radioreceptor assay and some clinical observations.
Calil HM; Avery DH; Hollister LE; Creese I; Snyder SH
Psychiatry Res; 1979 Jul; 1(1):39-44. PubMed ID: 45128
[TBL] [Abstract][Full Text] [Related]
6. Clinical state and serum neuroleptic levels measured by radioreceptor assay in schizophrenia.
Tune LE; Creese I; Depaulo JR; Slavney PR; Coyle JT; Snyder SH
Am J Psychiatry; 1980 Feb; 137(2):187-90. PubMed ID: 6101524
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic window of serum haloperidol concentration in acute schizophrenia and schizoaffective disorder.
Ulrich S; Neuhof S; Braun V; Meyer FP
Pharmacopsychiatry; 1998 Sep; 31(5):163-9. PubMed ID: 9832347
[TBL] [Abstract][Full Text] [Related]
8. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
[TBL] [Abstract][Full Text] [Related]
9. Low serum neuroleptic levels predict relapse in schizophrenic patients.
Brown WA; Laughren T; Chisholm E; Williams BW
Arch Gen Psychiatry; 1982 Sep; 39(9):998-1000. PubMed ID: 6126172
[TBL] [Abstract][Full Text] [Related]
10. Future of depot neuroleptic therapy: pharmacokinetic and pharmacodynamic approaches.
Ereshefsky L; Saklad SR; Jann MW; Davis CM; Richards A; Seidel DR
J Clin Psychiatry; 1984 May; 45(5 Pt 2):50-9. PubMed ID: 6143748
[TBL] [Abstract][Full Text] [Related]
11. Plasma drug and homovanillic acid levels in psychotic patients receiving neuroleptics.
Harris PQ; Brown SJ; Friedman MJ; Bacopoulos NG
Biol Psychiatry; 1984 Jun; 19(6):849-60. PubMed ID: 6146355
[TBL] [Abstract][Full Text] [Related]
12. Plasma level monitoring of antipsychotic drugs. Clinical utility.
Dahl SG
Clin Pharmacokinet; 1986; 11(1):36-61. PubMed ID: 2868820
[TBL] [Abstract][Full Text] [Related]
13. Serum effects confound the neuroleptic radioreceptor assay.
Mailman RB; DeHaven DL; Halpern EA; Lewis MH
Life Sci; 1984 Mar; 34(11):1057-64. PubMed ID: 6142394
[TBL] [Abstract][Full Text] [Related]
14. Neuroleptic plasma levels.
Van Putten T; Marder SR; Wirshing WC; Aravagiri M; Chabert N
Schizophr Bull; 1991; 17(2):197-216. PubMed ID: 1679251
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of Haloperidol, Fluphenazine, Perphenazine, and Thiothixene in Serum or Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
Slawson MH; Johnson-Davis KL
Methods Mol Biol; 2016; 1383():49-57. PubMed ID: 26660173
[TBL] [Abstract][Full Text] [Related]
16. Psychotic patients who become worse on neuroleptics.
Bowers MB; Swigar ME
J Clin Psychopharmacol; 1988 Dec; 8(6):417-21. PubMed ID: 2906948
[TBL] [Abstract][Full Text] [Related]
17. Neuroleptic drug level monitoring in psychiatry: focus on radioreceptor assay techniques.
Tune LE; Coyle JT
Ther Drug Monit; 1982; 4(1):59-64. PubMed ID: 6122293
[TBL] [Abstract][Full Text] [Related]
18. The strategy and value of neuroleptic drug monitoring.
Curry SH
J Clin Psychopharmacol; 1985 Oct; 5(5):263-71. PubMed ID: 2864358
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous UPLC-MS/MS assay for the detection of the traditional antipsychotics haloperidol, fluphenazine, perphenazine, and thiothixene in serum and plasma.
Juenke JM; Brown PI; Urry FM; Johnson-Davis KL; McMillin GA
Clin Chim Acta; 2013 Aug; 423():32-4. PubMed ID: 23618971
[TBL] [Abstract][Full Text] [Related]
20. Neuroleptic levels by radioreceptor assay and clinical response during treatment of acute exacerbation of schizophrenia--some preliminary findings.
Greenberg JS; Brown WA; Laughren TP; Krantz J
Psychopharmacol Bull; 1983; 19(1):74-6. PubMed ID: 6131470
[No Abstract] [Full Text] [Related]
[Next] [New Search]
